Literature DB >> 8980383

Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.

M Olivero1, M Rizzo, R Madeddu, C Casadio, S Pennacchietti, M R Nicotra, M Prat, G Maggi, N Arena, P G Natali, P M Comoglio, M F Di Renzo.   

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) stimulates the invasive growth of epithelial cells via the c-MET oncogene-encoded receptor. In normal lung, both the receptor and the ligand are detected, and the latter is known to be a mitogenic and a motogenic factor for both cultured bronchial epithelial cells and non-small-cell carcinoma lines. Here, ligand and receptor expression was examined in 42 samples of primary human non-small-cell lung carcinoma of different histotype. Each carcinoma sample was compared with adjacent normal lung tissue. The Met/HGF receptor was found to be 2 to 10-fold increased in 25% of carcinoma samples (P = 0.0113). The ligand, HGF/SF, was found to be 10 to 100-fold overexpressed in carcinoma samples (P < 0.0001). Notably, while HGF/SF was occasionally detectable and found exclusively as a single-chain inactive precursor in normal tissues, it was constantly in the biologically-active heterodimeric form in carcinomas. Immunohistochemical staining showed homogeneous expression of both the receptor and the ligand in carcinoma samples, whereas staining was barely detectable in their normal counterparts. These data show that HGF/SF is overexpressed and consistently activated in non-small-cell lung carcinomas and may contribute to the invasive growth of lung cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980383      PMCID: PMC2074802          DOI: 10.1038/bjc.1996.646

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  51 in total

1.  Tyrosine kinase receptor indistinguishable from the c-met protein.

Authors:  S Giordano; C Ponzetto; M F Di Renzo; C S Cooper; P M Comoglio
Journal:  Nature       Date:  1989-05-11       Impact factor: 49.962

2.  Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.

Authors:  R Rosell; S Li; Z Skacel; J L Mate; J Maestre; M Canela; E Tolosa; P Armengol; A Barnadas; A Ariza
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

3.  Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues.

Authors:  K Tashiro; M Hagiya; T Nishizawa; T Seki; M Shimonishi; S Shimizu; T Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII.

Authors:  K Miyazawa; T Shimomura; A Kitamura; J Kondo; Y Morimoto; N Kitamura
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

5.  Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury.

Authors:  K Yanagita; K Matsumoto; K Sekiguchi; H Ishibashi; Y Niho; T Nakamura
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

6.  Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells.

Authors:  M S Tsao; H Zhu; A Giaid; J Viallet; T Nakamura; M Park
Journal:  Cell Growth Differ       Date:  1993-07

7.  Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.

Authors:  W M Mars; R Zarnegar; G K Michalopoulos
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

8.  Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues.

Authors:  P G Natali; M R Nicotra; A Bigotti; I Venturo; D J Slamon; B M Fendly; A Ullrich
Journal:  Int J Cancer       Date:  1990-03-15       Impact factor: 7.396

9.  Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells.

Authors:  K M Weidner; J Behrens; J Vandekerckhove; W Birchmeier
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539

10.  Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.

Authors:  E Sonnenberg; D Meyer; K M Weidner; C Birchmeier
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

View more
  63 in total

1.  Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.

Authors:  Amy L McDoniels-Silvers; Gary D Stoner; Ronald A Lubet; Ming You
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

Review 2.  Molecular genetic abnormalities in the pathogenesis of human lung cancer.

Authors:  E Forgacs; S Zöchbauer-Müller; E Oláh; J D Minna
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

3.  Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.

Authors:  S Yi; M S Tsao
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 4.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

Review 5.  Future directions in the field of endometrial cancer research: the need to investigate the tumor microenvironment.

Authors:  A S Felix; J Weissfeld; R Edwards; F Linkov
Journal:  Eur J Gynaecol Oncol       Date:  2010       Impact factor: 0.196

Review 6.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

7.  Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells.

Authors:  S Scarpino; A Stoppacciaro; F Ballerini; M Marchesi; M Prat; M C Stella; S Sozzani; P Allavena; A Mantovani; L P Ruco
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 8.  Molecular mechanisms underlining the role of metformin as a therapeutic agent in lung cancer.

Authors:  Ali Fatehi Hassanabad; Kelsey T MacQueen
Journal:  Cell Oncol (Dordr)       Date:  2020-10-30       Impact factor: 6.730

Review 9.  Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy.

Authors:  Vikas Bhardwaj; Tina Cascone; Maria Angelica Cortez; Arya Amini; Jaden Evans; Ritsuko U Komaki; John V Heymach; James W Welsh
Journal:  Cancer       Date:  2013-02-19       Impact factor: 6.860

Review 10.  The multiple paths towards MET receptor addiction in cancer.

Authors:  Leslie Duplaquet; Zoulika Kherrouche; Simon Baldacci; Philippe Jamme; Alexis B Cortot; Marie-Christine Copin; David Tulasne
Journal:  Oncogene       Date:  2018-03-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.